L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats;

Shuangteng He1, Kenneth Grasing

  • 1Substance Abuse Research Laboratory, Kansas City Veterans Affairs Medical Center, 4801 Linwood Boulevard, Kansas City, MO 64128, USA.

Insights

Monoamine oxidase (MAO) inhibition and L-methamphetamine treatment differentially affect morphine reinforcement and non-reinforced behaviors. MAO-B inhibition with rasagiline showed the most prolonged decrease in morphine reinforcement.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Selegiline, a monoamine oxidase (MAO) inhibitor, exhibits psychostimulant properties and can reduce behaviors reinforced by morphine.
  • Understanding the distinct effects of MAO inhibition versus its psychostimulant metabolite, L-methamphetamine, is crucial for elucidating their impact on drug-seeking behaviors.

Purpose of the Study:

  • To compare the effects of MAO inhibition and L-methamphetamine on morphine-reinforced and non-reinforced behaviors in a rat model.
  • To investigate the specific roles of MAO-A and MAO-B inhibition in modulating opiate dependence and reinstatement.

Main Methods:

  • Rats self-administered morphine under a progressive ratio schedule to establish dependence.
  • Chronic treatments included vehicle, L-methamphetamine, clorgyline (MAO-A inhibitor), and rasagiline (MAO-B inhibitor) at selective and non-selective doses.
  • Behavioral responses during withdrawal, extinction, and reinstatement (cue- or morphine-induced) were recorded across multiple cycles.

Main Results:

  • Most behavioral measures remained consistent across initial and subsequent cycles of dependence and withdrawal.
  • All tested treatments (L-methamphetamine, clorgyline, rasagiline) reduced non-reinforced responding during extinction.
  • Morphine reinforcement was decreased by all active treatments, with rasagiline (MAO-B inhibition) demonstrating more potent and sustained effects.
  • Non-selective doses of clorgyline and rasagiline attenuated cue- and morphine-induced reinstatement, while selective doses did not.
  • L-methamphetamine affected cue-induced reinstatement minimally but reduced non-reinforced responding during morphine-induced reinstatement.

Conclusions:

  • Morphine reinforcement and various non-reinforced behaviors exhibit differential sensitivity to psychostimulant treatment and MAO inhibition.
  • MAO-B inhibition appears particularly effective in reducing morphine reinforcement and associated behaviors.
  • The findings highlight the complex interplay between MAO inhibition, psychostimulant effects, and opiate dependence, suggesting distinct mechanisms underlying different behavioral responses.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...